<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>66(Pt 5)</volume><submitter>Yin M</submitter><pubmed_abstract>The asymmetric unit of the title compound, (C(5)H(14)N(2))[ZnCl(4)], consists of a diprotonated 2-methyl-piperazine cation and a tetra-chloridozincate anion. The Zn(II) ion is in a slightly distorted tetra-hedral coordination environment. The six-membered piperazine ring adopts a chair conformation. The crystal structure is stabilized by inter-molecular N-H⋯Cl hydrogen bonds.</pubmed_abstract><journal>Acta crystallographica. Section E, Structure reports online</journal><pagination>m515</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2979142</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>2-Methyl-piperazinediium tetra-chlorido-zincate(II).</pubmed_title><pmcid>PMC2979142</pmcid><pubmed_authors>Yin M</pubmed_authors><pubmed_authors>Wu ST</pubmed_authors></additional><is_claimable>false</is_claimable><name>2-Methyl-piperazinediium tetra-chlorido-zincate(II).</name><description>The asymmetric unit of the title compound, (C(5)H(14)N(2))[ZnCl(4)], consists of a diprotonated 2-methyl-piperazine cation and a tetra-chloridozincate anion. The Zn(II) ion is in a slightly distorted tetra-hedral coordination environment. The six-membered piperazine ring adopts a chair conformation. The crystal structure is stabilized by inter-molecular N-H⋯Cl hydrogen bonds.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Apr</publication><modification>2025-04-04T14:42:41.218Z</modification><creation>2019-03-27T00:00:23Z</creation></dates><accession>S-EPMC2979142</accession><cross_references><pubmed>21579012</pubmed><doi>10.1107/S1600536810012547</doi></cross_references></HashMap>